Recordati Industria Chimica e Farmaceutica S.p.A. (RICFY)
OTCMKTS
· Delayed Price · Currency is USD
14.15
-0.09 (-0.63%)
Apr 28, 2025, 4:00 PM EDT
RICFY Revenue
In the year 2024, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.34B EUR with 12.45% growth. Recordati Industria Chimica e Farmaceutica had revenue of 598.48M in the quarter ending December 31, 2024, with 13.75% growth.
Revenue
2.34B EUR
Revenue Growth
+12.45%
P/S Ratio
5.09
Revenue / Employee
510.92K EUR
Employees
4,583
Market Cap
12.33B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.34B | 259.23M | 12.45% |
Dec 31, 2023 | 2.08B | 229.02M | 12.36% |
Dec 31, 2022 | 1.85B | 273.23M | 17.29% |
Dec 31, 2021 | 1.58B | 131.21M | 9.06% |
Dec 31, 2020 | 1.45B | -32.98M | -2.23% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |